- Home
- THFF vs PHAR Comparison
THFF vs PHAR Comparison
Compare THFF & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- PHAR
- Stock Information
- Founded
- THFF 1984
- PHAR 1988
- Country
- THFF United States
- PHAR Netherlands
- Employees
- THFF N/A
- PHAR N/A
- Industry
- THFF Major Banks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- PHAR Health Care
- Exchange
- THFF Nasdaq
- PHAR Nasdaq
- Market Cap
- THFF 599.3M
- PHAR 618.3M
- IPO Year
- THFF N/A
- PHAR N/A
- Fundamental
- Price
- THFF $49.96
- PHAR $8.20
- Analyst Decision
- THFF Hold
- PHAR Strong Buy
- Analyst Count
- THFF 1
- PHAR 3
- Target Price
- THFF $45.00
- PHAR $27.00
- AVG Volume (30 Days)
- THFF 46.4K
- PHAR 5.6K
- Earning Date
- THFF 02-11-2025
- PHAR 03-13-2025
- Dividend Yield
- THFF 4.11%
- PHAR N/A
- EPS Growth
- THFF N/A
- PHAR N/A
- EPS
- THFF 4.00
- PHAR N/A
- Revenue
- THFF $201,592,000.00
- PHAR $285,745,000.00
- Revenue This Year
- THFF N/A
- PHAR $20.08
- Revenue Next Year
- THFF $11.39
- PHAR $9.22
- P/E Ratio
- THFF $12.41
- PHAR N/A
- Revenue Growth
- THFF N/A
- PHAR 30.64
- 52 Week Low
- THFF $34.58
- PHAR $6.65
- 52 Week High
- THFF $51.87
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- THFF 56.31
- PHAR 36.29
- Support Level
- THFF $47.42
- PHAR $8.49
- Resistance Level
- THFF $49.23
- PHAR $9.35
- Average True Range (ATR)
- THFF 1.35
- PHAR 0.55
- MACD
- THFF 0.26
- PHAR -0.17
- Stochastic Oscillator
- THFF 75.81
- PHAR 12.14
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.